Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2928

Actual shortage: 212 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 2706 (92%)

Discontinuation Reports

299

To be discontinued: 2 (1%)
Discontinued: 297 (99%)
Reversed: 0 (0%)

Late reports

361 (11%)

Overdue reports

85 (40%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2024-04-05 2024-06-07 224445
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2024-04-18 2024-05-16 225492
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2024-06-20 2025-01-30 230958
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2024-06-20 2025-02-06 230961
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2024-07-11 2025-02-20 232747
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2022-05-12 2022-11-12 160427
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2022-05-12 2022-11-12 160432
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-11 2021-04-29 133770
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-11 2021-05-27 133776
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2021-06-10 2021-09-30 140675
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2023-04-27 2023-06-09 190728
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-09 2023-12-07 209672
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-09 2020-08-27 119889
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-16 2021-09-30 120473
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2022-01-27 2022-11-12 153709
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2022-02-17 2022-03-24 155137
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2022-03-10 2022-03-24 156407
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2025-01-23 2025-03-04 248445
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2025-02-20 2025-03-27 250909
TEVA-BUSPIRONE 10MG TABLET Resolved 2024-04-25 2025-03-13 226174

Showing 881 to 900 of 2928

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-12 2018-10-12 63943
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-19 2018-10-19 64891
TEVA-LENOLTEC NO. 1 300MG 8MG 15MG TABLET Discontinued 2019-04-11 2019-04-11 81362
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64595
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64598
RATIO-METFORMIN 850MG TABLET Discontinued 2020-07-10 2020-07-10 120012
RATIO-NYSTATIN 100000UNIT CREAM Discontinued 2019-10-25 2019-10-26 97243
RATIO-NYSTATIN 100000UNIT CREAM Discontinued 2020-02-13 2020-02-13 106148
RATIO-NYSTATIN 100000UNIT CREAM Discontinued 2019-10-25 2019-10-26 97261
RATIO-SALBUTAMOL Discontinued 2020-02-13 2020-02-13 106151
RATIO-TAMSULOSIN 0.4MG CAPSULE (SUSTAINED-RELEASE) Discontinued 2018-10-19 2018-10-19 64917
RATIO-TOPISALIC 20MG 0.5MG LOTION Discontinued 2024-06-28 2024-06-29 231583
TEVA-ACYCLOVIR 800MG TABLET Discontinued 2025-04-29 2025-04-29 256128
TEVA-ACYCLOVIR 200MG TABLET Discontinued 2025-04-29 2025-04-29 256122
TEVA-ACYCLOVIR 400MG TABLET Discontinued 2025-04-29 2025-04-29 256125
TEVA-AMITRIPTYLINE 10MG TABLET Discontinued 2020-10-22 2020-10-24 126903
TEVA-AMITRIPTYLINE 50MG TABLET Discontinued 2020-10-22 2020-10-24 126900
TEVA-AMITRIPTYLINE 25MG TABLET Discontinued 2022-01-07 2022-01-07 152351
TEVA-AMITRIPTYLINE 10MG TABLET Discontinued 2020-09-24 2020-09-24 124896
TEVA-AMITRIPTYLINE 25MG TABLET Discontinued 2022-01-07 2022-01-07 152375

Showing 101 to 120 of 299